Seok-Hwan Kim

Prof. Dr. Seok-Hwan Kim

Chungnam National University, Daejeon, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 July 2020 in Aging Cell
Verified
Journal Article
Open access
PDF file
JMJi Sun Moon
Ji Sun Moon
LGLudger J. E. Goeminne
Ludger J. E. Goeminne
JKJung Tae Kim
Jung Tae Kim
JTJing Wen Tian
Jing Wen Tian
SKSeok-Hwan Kim
Seok-Hwan Kim
HYHyon-Seung Yi
Hyon-Seung Yi
Mitochondrial dysfunction is associated with aging‐mediated inflammatory responses, leading to metabolic deterioration, development of insulin resistance, and type 2 diabetes. Growth differentiation factor 15 (GDF15) is an important mitokine generated in response to mitochondrial stress and dysfunction; however, the implications of GDF15 to the aging process are poorly understood in mammals. In this study, we identified a link between mitochondrial stress‐induced GDF15 production and protection from tissue inflammation on aging in humans and mice. We observed an increase in serum levels and hepatic expression of GDF15 as well as pro‐inflammatory cytokines in elderly subjects. Circulating levels of cell‐free mitochondrial DNA were significantly higher in elderly subjects with elevated serum levels of GDF15. In the BXD mouse reference population, mice with metabolic impairments and shorter survival were found to exhibit higher hepatic Gdf15 expression. Mendelian randomization links reduced GDF15 expression in human blood to increased body weight and inflammation. GDF15 deficiency promotes tissue inflammation by increasing the activation of resident immune cells in metabolic organs, such as in the liver and adipose tissues of 20‐month‐old mice. Aging also results in more severe liver injury and hepatic fat deposition in Gdf15‐deficient mice. Although GDF15 is not required for Th17 cell differentiation and IL‐17 production in Th17 cells, GDF15 contributes to regulatory T‐cell‐mediated suppression of conventional T‐cell activation and inflammatory cytokines. Taken together, these data reveal that GDF15 is indispensable for attenuating aging‐mediated local and systemic inflammation, thereby maintaining glucose homeostasis and insulin sensitivity in humans and mice.

15 September 2015 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
GSG.-W. Song
G.-W. Song
SLS.-G. Lee
S.-G. Lee
SHS. Hwang
S. Hwang
KKK.-H. Kim
K.-H. Kim
CAC.-S. Ahn
C.-S. Ahn
ETE.-Y. Tak
E.-Y. Tak
ABO incompatibility is no longer considered a contraindication for adult living donor liver transplantation (ALDLT) due to various strategies to overcome the ABO blood group barrier. We report the largest single‐center experience of ABO‐incompatible (ABOi) ALDLT in 235 adult patients. The desensitization protocol included a single dose of rituximab and total plasma exchange. In addition, local graft infusion therapy, cyclophosphamide, or splenectomy was used for a certain time period, but these treatments were eventually discontinued due to adverse events. There were three cases (1.3%) of in‐hospital mortality. The cumulative 3‐year graft and patient survival rates were 89.2% and 92.3%, respectively, and were comparable to those of the ABO‐compatible group (n = 1301). Despite promising survival outcomes, 17 patients (7.2%) experienced antibody‐mediated rejection that manifested as diffuse intrahepatic biliary stricture; six cases required retransplantation, and three patients died. ABOi ALDLT is a feasible method for expanding a living liver donor pool, but the efficacy of the desensitization protocol in targeting B cell immunity should be optimized.

8 May 2020 in Hepatology
Verified
Journal Article
Closed access
JLJun-Hee Lee
Jun-Hee Lee
YSYoung‐Ri Shim
Young‐Ri Shim
WSWonhyo Seo
Wonhyo Seo
MKMyung‐Ho Kim
Myung‐Ho Kim
WCWon-Mook Choi
Won-Mook Choi
WJWON-IL JEONG
WON-IL JEONG

1 November 2019 in Cell Metabolism
Verified
Journal Article
Closed access
WCWon-Mook Choi
Won-Mook Choi
HKHee-Hoon Kim
Hee-Hoon Kim
MKMyung-Ho Kim
Myung-Ho Kim
RCResat Cinar
Resat Cinar
HYHyon-Seung Yi
Hyon-Seung Yi
WJWON-IL JEONG
WON-IL JEONG

1 January 2017 in Toxicology and Applied Pharmacology
Verified
Journal Article
Open access
ETEunyoung Tak
Eunyoung Tak
DJDong-Hwan Jung
Dong-Hwan Jung
SKSeok-Hwan Kim
Seok-Hwan Kim
GPGil-Chun Park
Gil-Chun Park
DJDae Young Jun
Dae Young Jun
SLSung-Gyu Lee
Sung-Gyu Lee
Acute liver failure (ALF) is a severe life-threatening disease which usually arises in patients with-irreversible liver illnesses. Although human ectonucleotide triphosphate diphosphohydrolase-1, E-NTPDase1 (CD39) and ecto-5'-nucleotidase, Ecto5'NTase (CD73) are known to protect tissues from ALF, the expression and function of CD39 and CD73 during ALF are currently not fully investigated. We tested whether CD39 and CD73 are upregulated by hypoxia inducible factor (HIF)-1α, and improve ischemic tolerance to ALF. To test our hypothesis, liver biopsies were obtained and we found that CD39 and CD73 mRNA and proteins from human specimens were dramatically elevated in ALF. We investigated that induction of CD39 and CD73 in ALF-related with wild type mice. In contrast, deletion of cd39 and cd73 mice has severe ALF. In this study, we concluded that CD39 and CD73 are molecular targets for the development of drugs for ALF patients care.

1 May 2021 in Hepatology
Verified
Journal Article
Closed access
PDF file
WCWon-Mook Choi
Won-Mook Choi
TRTom Ryu
Tom Ryu
JLJun-Hee Lee
Jun-Hee Lee
YSYoung‐Ri Shim
Young‐Ri Shim
MKMyung‐Ho Kim
Myung‐Ho Kim
WJWON-IL JEONG
WON-IL JEONG